Latest news with #StateKeyLaboratoryofTargetingOncology
Iraqi News
20-03-2025
- Health
- Iraqi News
Chinese scientists develop cancer treatment that makes tumors mimic ‘pork'
INA- SOURCES Chinese scientists have developed a pioneering cancer treatment that modifies tumors to resemble 'pork,' effectively triggering the body's immune system to attack them, according to a report by the South China Morning Post on Monday. The researchers have engineered tumors to mimic pig tissue, prompting the immune system to recognize them as foreign and launch a targeted attack using the same response that leads to organ transplant rejection. The study, published in Cell on Jan. 18, employs a genetically modified virus to disguise cancer cells as pig tissue, inducing a hyperacute immune rejection that specifically targets tumors while sparing healthy cells. Early clinical trials have shown remarkable results, with 90% of patients suffering from advanced, treatment-resistant cancers experiencing either halted tumor growth or shrinkage. One cervical cancer patient was even declared clinically cured. This breakthrough offers new hope for patients whose cancers have not responded to conventional therapies, opening a promising new direction in oncology. The research, led by Professor Zhao Yongxiang, director of the State Key Laboratory of Targeting Oncology at Guangxi Medical University, has gained widespread attention on Chinese social media.
South China Morning Post
17-03-2025
- Health
- South China Morning Post
Chinese scientists turn tumours into ‘pork' in radical cancer treatment
Scientists have turned the same immune response that rejects organ transplants to their advantage – to target cancer Advertisement In a trailblazing fusion of immunology and ingenuity, a team of Chinese researchers have been engineering tumours to mimic pork, thereby triggering the body's immune system to attack them with unprecedented precision. Their pioneering study, published in the journal Cell on January 18, uses a genetically modified virus to 'disguise' cancer cells as foreign pig tissue, sparking a hyperacute immune rejection response that attacks the tumours while leaving healthy cells untouched. Early clinical trials report staggering success: 90 per cent of patients with advanced, treatment-resistant cancers – such as liver, ovarian and lung – achieved halted tumour growth or shrinkage, with one cervical cancer patient declared clinically cured. By repurposing a mechanism that is notorious for organ transplant rejection, this 'tumour-to-pork' strategy has opened a new frontier in the fight against cancer, offering hope where conventional therapies have failed. Advertisement The study, led by Professor Zhao Yongxiang, director of the State Key Laboratory of Targeting Oncology, Guangxi Medical University, is now trending on China's social media.
